Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Mytrex Health Technologies's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$-16 Mil. Mytrex Health Technologies's average total tangible assets for the quarter that ended in Dec. 2025 was NT$1,079 Mil. Therefore, Mytrex Health Technologies's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was -1.47%.
The historical rank and industry rank for Mytrex Health Technologies's Return-on-Tangible-Asset or its related term are showing as below:
ROCO:4431'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -7.81 Med: 0.48 Max: 40.72
Current: -1.55
During the past 13 years, Mytrex Health Technologies's highest Return-on-Tangible-Asset was 40.72%. The lowest was -7.81%. And the median was 0.48%.
ROCO:4431's Return-on-Tangible-Asset is ranked worse than 77.96% of 3076
companies
in the Industrial Products industry
Industry Median: 3.335
vs ROCO:4431: -1.55
Mytrex Health Technologies (ROCO:4431) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Mytrex Health Technologies Return-on-Tangible-Asset Related Terms
Mytrex Health Technologies Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mytrex Health Technologies Return-on-Tangible-Asset Chart
ROCO:4431 vs GEV, ETN, PH: Return-on-Tangible-Asset Comparison
For the Specialty Industrial Machinery subindustry, Mytrex Health Technologies's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mytrex Health Technologies Return-on-Tangible-Asset vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Mytrex Health Technologies's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Mytrex Health Technologies's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of -1.47% mean?
Mytrex Health Technologies (ROCO:4431) has a Return-on-Tangible-Asset of -1.47% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Mytrex Health Technologies and its competitors. According to the industry distribution chart, Mytrex Health Technologies ranks #2398 out of 3076 companies in the Industrial Products industry, placing it in the top 78%.
Is Mytrex Health Technologies' Return-on-Tangible-Asset too high?
Mytrex Health Technologies' current Return-on-Tangible-Asset is -1.47%. Based on the distribution chart, Mytrex Health Technologies ranks #2398 out of 3076 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Mytrex Health Technologies has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mytrex Health Technologies' Return-on-Tangible-Asset compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Mytrex Health Technologies ranks #2398 out of 3076 companies for Return-on-Tangible-Asset. This places Mytrex Health Technologies in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for an Industrial Products company?
The median Return-on-Tangible-Asset among Industrial Products companies is 3.34, based on 3,076 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Mytrex Health Technologies and its competitors. For the Industrial Products industry, the median Return-on-Tangible-Asset is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mytrex Health Technologies's current Return-on-Tangible-Asset is -1.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mytrex Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mytrex Health Technologies (ROCO:4431) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$37.43, compared to a current price of NT$18.45 — trading 50.7% below its estimated fair value. The current Return-on-Tangible-Asset is -1.47%. Mytrex Health Technologies' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Mytrex Health Technologies (ROCO:4431), the current Return-on-Tangible-Asset is -1.47% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?
Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued.
The current stock price of NT$18.45 is trading 50.7% below its estimated GF Value™ of NT$37.43.
GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.
Key valuation signals for ROCO:4431:
Return-on-Tangible-Asset: -1.47%
GF Value™: NT$37.43 vs. price of NT$18.45 (50.7% below fair value)
No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
63GF Score
Get the complete analysis for ROCO:4431
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4431 has been successfully added to your 
